Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
description Rank Gene Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 551 to 600 of 6456 in total
Value Type  : Ranked
Interaction Map  : High confidence
Filtered  : 1
description
Rank
Network Comparison Type
red
green
network_comparison
anaphase promoting complex subunit 11 (hepatocellular carcinoma associated ring finger protein) (hspc214). [swissprot;acc:q9nyg5] 2636 Divided 195.635 195.384 1.00128
2639 Subtracted 0.251
anaphase-promoting complex subunit 10; anaphase-promoting complex 10. [refseq;acc:nm_014885] 2663 Divided 204.768 204.549 1.00107
2667 Subtracted 0.219
anaphase-promoting complex subunit 2; anaphase-promoting complex 2. [refseq;acc:nm_013366] 2679 Divided 190.142 189.959 1.00096
2682 Subtracted 0.183
androgen-induced 1; cgi-103 protein; androgen induced protein. [refseq;acc:nm_016108] 184 227.357 254.15 26.793
240 Divided 1.11785
angiomotin like 2; leman coiled-coil protein; angiomotin-like protein 2. [refseq;acc:nm_016201] 2586 213.422 213.75 1.00154
Subtracted 0.328
angiomotin. [refseq;acc:nm_133265] 2585 Divided 1.00154
Subtracted 0.328
anillin, actin binding protein (scraps homolog, drosophila); anillin (drosophila scraps homolog), actin binding protein. [refseq;acc:nm_018685] 143 Divided 59 49 1.20408
773 Subtracted 10
ankyrin 2 (brain ankyrin) (ankyrin b) (ankyrin, nonerythroid). [swissprot;acc:q01484] 2516 215.835 216.341 0.506
2519 Divided 1.00234
ankyrin 3 (ank-3) (ankyrin g). [swissprot;acc:q12955] 2515 Subtracted 0.506
2518 Divided 1.00234
ankyrin-repeat family a protein 2 (rfxank-like 2). [swissprot;acc:q9h9e1] 793 Subtracted 212.386 221.785 9.399
805 Divided 1.04425
annexin a11 (annexin xi) (calcyclin-associated annexin 50) (cap-50) (56 kda autoantigen). [swissprot;acc:p50995] 1051 Subtracted 219.673 213.378 6.295
1088 Divided 1.0295
annexin a7 (annexin vii) (synexin). [swissprot;acc:p20073] 1053 Subtracted 219.655 213.385 6.27
1094 Divided 1.02938
antithrombin-iii precursor (atiii) (pro0309). [swissprot;acc:p01008] 2406 Subtracted 218.2 218.984 0.784
2418 Divided 1.00359
apg3p; pc3-96 protein. [refseq;acc:nm_022488] 169 82.5916 98.0548 1.18722
489 Subtracted 15.4632
apical-like protein (apxl protein). [swissprot;acc:q13796] 346 231.492 211.136 20.356
362 Divided 1.09641
apobec-1 complementation factor isoform 1; apobec-1 stimulating protein; apo-b rna editing protein. [refseq;acc:nm_014576] 211 Subtracted 237.302 212.41 24.892
248 Divided 1.11719
apolipoprotein a-i binding protein; apoa-i binding protein. [refseq;acc:nm_144772] 1606 207.916 204.662 1.0159
1609 Subtracted 3.254
apolipoprotein b-100 precursor (apo b-100) [contains: apolipoprotein b-48 (apo b-48)]. [swissprot;acc:p04114] 2128 217.871 219.366 1.495
2151 Divided 1.00686
apopain precursor (ec 3.4.22.-) (cysteine protease cpp32) (yama protein) (cpp-32) (caspase-3) (casp-3) (srebp cleavage activity 1) (sca-1). [swissprot;acc:p42574] 1166 Subtracted 233.942 228.46 5.482
1293 Divided 1.024
apoptosis antagonizing transcription factor. [refseq;acc:nm_012138] 929 Subtracted 243.045 235.422 7.623
1014 Divided 1.03238
apoptosis inhibitor 5; fibroblast growth factor 2-interacting factor 2; api5-like 1. [refseq;acc:nm_006595] 1094 Subtracted 218.484 212.675 5.809
1132 Divided 1.02731
apoptosis inhibitor fksg2. [swissprot;acc:q9hau6] 1083 Subtracted 217.99 212.123 5.867
1111 Divided 1.02766
apoptosis-inducing factor (aif)-homologous mitochondrion-associated inducer of death; p53-responsive gene 3. [refseq;acc:nm_032797] 2418 Subtracted 210.205 209.454 0.751
2421 Divided 1.00359
apurinic/apyrimidinic endonuclease 2; apurinic/apyrimidinic endonuclease-like 2; apex nuclease-like 2. [refseq;acc:nm_014481] 2523 Subtracted 216.264 215.787 0.477
2531 Divided 1.00221
aquaporin 4 (wch4) (mercurial-insensitive water channel) (miwc). [swissprot;acc:p55087] 2688 Subtracted 188.191 188.046 0.145
2690 Divided 1.00077

Legend:
- Rank is the rank after comparing the two networks
- Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
- Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
- Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
- Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
- Filtered specifies whether we only included the high confidence microarry measurements or not.

- http://analysis.yellowcouch.org/